Nelaj E, Kecaj I, Feracaku J, Xhixhabesi K, Tase M. Benefits of SGLT2 inhibitors on renal and cardiovascular protection, in diabetic patients. SEEJPH [Internet]. 2024 Aug. 29 [cited 2025 Nov. 4];:200-6. Available from: https://seejph.com/index.php/seejph/article/view/689